12:00 AM
 | 
Jul 02, 2012
 |  BC Week In Review  |  Clinical News  |  Regulatory

Lyme disease Line Immunoassay regulatory update

Gold Standard said FDA approved its Lyme disease Line Immunoassay (LIA) to diagnose Lyme disease. The...

Read the full 56 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$30 USD
More Info >